Cargando...
Successful treatment of refractory TAFRO syndrome with elevated vascular endothelial growth factor using thyroxine supplements
Although the clinical significance of hypothyroidism in TAFRO syndrome is unknown, vascular endothelial growth factor (VEGF) levels decreased with improvements in the condition of our refractory TAFRO cases after thyroxine supplement therapy. Our results indicate that elevated VEGF levels are a pote...
Guardado en:
| Publicado en: | Clin Case Rep |
|---|---|
| Autores principales: | , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
John Wiley and Sons Inc.
2018
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5889265/ https://ncbi.nlm.nih.gov/pubmed/29636932 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ccr3.1430 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|